Closing on Nov. 3: Investor Calendar + Company Spotlight

INVESTOR NETWORK is the go-to, one-stop site for shareholders, clients and prospective investors

Trimeris, Inc.

Trimeris, Inc.

Sector: Pharmaceutical Preparations Region: NC, United States

Similar to: Recordati SpA, Pernix Therapeutics Holdings, Inc., Imprimis Pharmaceuticals, Inc.

Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC.

× We're Sorry! We do not have an investor kit available for this company. Tell us you want one!

News & Analysis

You may also be interested in: